Literature DB >> 10521737

Fetal rat brain damage caused by maternal seizure activity: prevention by magnesium sulfate.

M Hallak1, W J Kupsky, J W Hotra, J B Evans.   

Abstract

OBJECTIVE: Our purpose was to determine whether maternal rat seizure activity was associated with fetal histopathologic brain changes and whether magnesium sulfate reduced these changes. STUDY
DESIGN: Electrodes were stereotaxically implanted into the hippocampus of nonpregnant rats 1 week before breeding. Pregnant rats were randomly assigned to 1 of 4 groups: (1) sodium chloride solution and no seizure (n = 2), (2) magnesium sulfate and no seizure (n = 2), (3) sodium chloride solution and seizure (n = 5), and (4) magnesium sulfate and seizure (n = 5). On gestational days 9, 11, 13, 15, 17, and 19, subcutaneous doses of sodium chloride solution or magnesium sulfate were administered to all rats every 20 minutes for 4 hours (loading-maintenance-loading), followed by seizure induction. On gestational day 20, the rats were perfused with formalin and fetuses were delivered via cesarean. Fetuses were perfused with formalin, brains were obtained and embedded in paraffin, and the forebrain and hindbrain were sectioned in the coronal plane and stained with hematoxylin and eosin. A neuropathologist masked to the protocol performed histopathologic grading of each section, including extent and nature of cellular damage. Eleven brain regions were examined in each section. Scores were expressed as mean +/- SD. Kruskal-Wallis analysis of variance was used, and P <.05 was considered significant.
RESULTS: We evaluated 26 fetal brains in group 1, 9 in group 2, 72 in group 3, and 45 in group 4. Fetuses in the sodium chloride solution-and-seizure group (group 3) presented significantly higher grades of neuronal damage in the hippocampus (group 1, 0.50 +/- 0. 88; group 2, 0.22 +/- 0.66; group 3, 1.01 +/- 1.17; and group 4, 0. 48 +/- 0.72) and in the tegmentum region (group 1, 1.0 +/- 1.0; group 2, 0.8 +/- 1.0; group 3, 1.7 +/- 0.7; and group 4, 1.5 +/- 0. 8) (P <.05, group 3 compared with others). Isolated and patchy neuronal injury with shrinkage of cells, nuclear pyknosis, and karyorrhexis were the main histologic findings.
CONCLUSIONS: Maternal rat seizure activity was associated with histologic brain injury in the fetus. Maternal administration of magnesium sulfate before seizure prevented or significantly decreased this effect.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10521737     DOI: 10.1016/s0002-9378(99)70309-1

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  6 in total

Review 1.  In utero exposure to antiepileptic drugs: teratogenicity and neonatal morbidity.

Authors:  Tarannum Musvee Lateef; Karin B Nelson
Journal:  Curr Neurol Neurosci Rep       Date:  2007-03       Impact factor: 5.081

2.  Morphometrical study of polysialylated neural cell adhesion molecule positive cells in rat pups hippocampus following induction of seizure during pregnancy.

Authors:  Ali Akbar Rajabzadeh; Ali Reza Ebrahimzadeh Bideskan; Hossein Haghir; Ali Reza Fazel
Journal:  Iran Biomed J       Date:  2011

Review 3.  Antiepileptic drugs and neurodevelopment.

Authors:  Gholam K Motamedi; Kimford J Meador
Journal:  Curr Neurol Neurosci Rep       Date:  2006-07       Impact factor: 5.081

Review 4.  Teratogenicity of antiepileptic medications.

Authors:  Benzi M Kluger; Kimford J Meador
Journal:  Semin Neurol       Date:  2008-07-24       Impact factor: 3.420

5.  The effect of PTZ-induced epileptic seizures on hippocampal expression of PSA-NCAM in offspring born to kindled rats.

Authors:  Aliakbar Rajabzadeh; Alireza Ebrahimzadeh Bideskan; Alireza Fazel; Mojtaba Sankian; Houshang Rafatpanah; Hossein Haghir
Journal:  J Biomed Sci       Date:  2012-05-31       Impact factor: 8.410

6.  Effect of magnesium sulfate on hyperthermia and pentylen-tetrazol-induced seizure in developing rats.

Authors:  Maryam Ghadimkhani; Ehsan Saboory; Shiva Roshan-Milani; Sedra Mohammdi; Yousef Rasmi
Journal:  Iran J Basic Med Sci       Date:  2016-06       Impact factor: 2.699

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.